Samsung has secured U.S. Food and Drug Administration clearance for an upgraded sleep apnea detection feature on its Galaxy Ring and Galaxy Watch 9, marking a significant step forward for wearable health monitoring. The enhanced capability, which uses AI to estimate how often breathing is interrupted per hour of sleep, is now rolling out to users after regulatory approvals from both the FDA and South Korea’s MFDS.
- FDA clearance: The advanced feature was authorized by the FDA in July 2026 and by Korea’s MFDS in October, enabling a broader rollout.
- Expanded detection: Unlike the previous version that only flagged moderate-to-severe cases, the new system also identifies mild sleep apnea.
- Device availability: The feature is live on the Galaxy Ring and Galaxy Watch 9, with updates planned for the Watch 7 and Watch 8.
How the advanced detection works
The upgraded system estimates the frequency of respiratory interruptions during sleep and classifies them as mild, occasional, or frequent. According to Samsung, the feature relies on AI to calculate how often breathing pauses occur, with results displayed in the Samsung Health Monitor app. To generate a reading, users must accumulate at least five hours of sleep across two nights within a ten-day window.
The Galaxy Watch 9 requires Wear OS 7.0 or later to access the functionality. Samsung initially obtained clearance for a sleep apnea feature in February 2024, but that version was limited to detecting moderate-to-severe cases. The new authorization represents a qualitative leap, as it now captures milder forms of the condition.
Samsung is careful to frame the feature as a screening aid rather than a diagnostic tool. The company emphasizes that only a physician can diagnose sleep apnea, but notes that the data can help users have more productive conversations with healthcare professionals. This cautious positioning aligns with broader industry guidance on wearables, which are increasingly capable of tracking health metrics but remain subject to regulatory limits.
Competitive landscape and market context
The FDA clearance gives Samsung a notable edge over rivals such as Oura and Superhuman, neither of which offers FDA-approved sleep apnea detection, though they do track nighttime disturbances. Samsung and Oura are also locked in patent litigation over smart rings, underscoring the intensifying competition in the wearable segment. The Galaxy Ring now operates in a crowded market that includes established players and newer entrants like Casio’s smart ring.
Sleep apnea remains widely underdiagnosed, and many people are unaware they have the condition. A consumer device that can flag potential cases—including mild ones—could serve as a valuable first step toward medical evaluation. However, experts caution that an estimate is not a diagnosis. A “not detected” result does not rule out the condition, just as a “frequent” classification does not confirm it. Samsung’s explicit reminder that the feature is not a substitute for professional medical advice is therefore essential.
What it means for users and the wearable market
For consumers, the update transforms the Galaxy Ring from a general wellness tracker into a more clinically relevant screening tool. The ability to detect mild apnea could prompt earlier intervention for individuals who might otherwise go undiagnosed for years. The rollout to older Galaxy Watch models via software update also extends the feature’s reach to existing users.
From a strategic standpoint, Samsung’s FDA clearance reinforces its position in the health-focused wearable space. Regulatory validation is becoming a key differentiator, and Samsung has now cleared a higher bar than some competitors. As smart rings and watches accumulate more medical-grade capabilities, the line between consumer gadgets and clinical devices will continue to blur. Samsung’s careful messaging—positioning the feature as a conversation starter rather than a diagnostic endpoint—suggests the company is aware of that boundary and intends to respect it while still pushing the technology forward.